Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects
Clinical trial NCT01624714 · UNKNOWN
Trial details
- NCT number
- NCT01624714
- Sponsor
- Samuel Forrester Hunter, MD, PhD
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2017-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.